| pubmed-article:7839471 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C1510986 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0596402 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0023828 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0443224 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0332256 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:7839471 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:7839471 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7839471 | pubmed:dateCreated | 1995-3-2 | lld:pubmed |
| pubmed-article:7839471 | pubmed:abstractText | The purpose of the present study was to investigate whether human recombinant interferon-gamma (hrIFN-gamma) can act synergically with various activators in increasing the cytotoxicity of cancer patient monocytes against fresh autologous and allogeneic tumor cells. | lld:pubmed |
| pubmed-article:7839471 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7839471 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7839471 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7839471 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7839471 | pubmed:issn | 0300-8916 | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:SpadaAA | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:GalligioniEE | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:TalaminiRR | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:QuaiaMM | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:FavaroDD | lld:pubmed |
| pubmed-article:7839471 | pubmed:author | pubmed-author:SantarosaMM | lld:pubmed |
| pubmed-article:7839471 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7839471 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:7839471 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:7839471 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7839471 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7839471 | pubmed:pagination | 385-91 | lld:pubmed |
| pubmed-article:7839471 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:meshHeading | pubmed-meshheading:7839471-... | lld:pubmed |
| pubmed-article:7839471 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7839471 | pubmed:articleTitle | In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells. | lld:pubmed |
| pubmed-article:7839471 | pubmed:affiliation | Divisione di Oncologia Medica, Centro di Riferimento Oncologico, Aviano (PN), Italy. | lld:pubmed |
| pubmed-article:7839471 | pubmed:publicationType | Journal Article | lld:pubmed |
